Introduction Cuba has emerged as a global leader in cancer immunotherapy, pioneering therapeutic vaccines, monoclonal antibodies, and interferon-based treatments. With a strong emphasis on biotechnology and medical research, Cuban scientists have developed groundbreaking therapies that improve survival rates, minimize side effects, and provide affordable cancer care. This article explores CIMAvax-EGF, Racotumomab (Vaxira), Nimotuzumab (CimaHER), Interferon...
